On March 3, 2020, the NRC issued a Notice of Violation to Sanders Medical Products (SMP) for two Severity Level III violations. The first violation involved SMP not filing an application for a specific license to the Deputy Director of the Office of International Programs, to export a Ge-68 1,581 µCi source, using an appropriate method listed in 10 CFR Part 110.4. Specifically, on June 3, 2019, SMP attempted to export a Ge-68 1,581 µCi source to Tehran, Iran, without filing an application for a specific license, when such activity would have been required to be authorized by the NRC. Therefore, no export application was filed, and the shipment was not authorized by a specific license issued under 10 CFR Part 110. The second violation involved SMP exporting a Ge-68 1,581 µCi source without being authorized by a specific license issued under 10 CFR Part 110. Specifically, on November 26, 2018, SMP exported to Alchemy Scientific Bureau in Baghdad, Iraq, a Ge-68 1,581 µCi source without a specific license, when such activity would have been required to be authorized by the NRC. Therefore, no export license was issued, and the shipment was not authorized by a specific license issued under 10 CFR Part 110.